CY1117126T1 - Σφαιριδια φορεα, μεθοδος για την παραγωγη τους και τη χρηση τους - Google Patents
Σφαιριδια φορεα, μεθοδος για την παραγωγη τους και τη χρηση τουςInfo
- Publication number
- CY1117126T1 CY1117126T1 CY20151100979T CY151100979T CY1117126T1 CY 1117126 T1 CY1117126 T1 CY 1117126T1 CY 20151100979 T CY20151100979 T CY 20151100979T CY 151100979 T CY151100979 T CY 151100979T CY 1117126 T1 CY1117126 T1 CY 1117126T1
- Authority
- CY
- Cyprus
- Prior art keywords
- production
- body bodies
- carrier pellets
- active substances
- pharmaceutically active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Glanulating (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Η εφεύρεση αναφέρεται σε μία μέθοδο για την παραγωγή σφαιριδίων φορέα για φαρμακευτικές δραστικές ουσίες. Ομοίως, η εφεύρεση αναφέρεται σε τέτοιου είδους σφαιρίδια φορέα καθώς και σε φαρμακευτικά σκευάσματα που τα περιέχουν. Σύμφωνα με την εφεύρεση χρησιμοποιούνται σφαιρίδια φορέα για τη μεταφορά και την αποδέσμευση φαρμακευτικών δραστικών ουσιών, ιδίως στο ανθρώπινο σώμα.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008004893A DE102008004893A1 (de) | 2008-01-17 | 2008-01-17 | Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung |
EP09702374.1A EP2244696B1 (de) | 2008-01-17 | 2009-01-12 | Trägerpellets, verfahren zu deren herstellung und deren verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1117126T1 true CY1117126T1 (el) | 2017-04-05 |
Family
ID=40473941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20151100979T CY1117126T1 (el) | 2008-01-17 | 2015-11-03 | Σφαιριδια φορεα, μεθοδος για την παραγωγη τους και τη χρηση τους |
Country Status (12)
Country | Link |
---|---|
US (3) | US20110097411A1 (el) |
EP (2) | EP2949320A1 (el) |
CY (1) | CY1117126T1 (el) |
DE (1) | DE102008004893A1 (el) |
DK (1) | DK2244696T3 (el) |
ES (1) | ES2552172T3 (el) |
HR (1) | HRP20151132T1 (el) |
HU (1) | HUE026364T2 (el) |
PL (1) | PL2244696T3 (el) |
PT (1) | PT2244696E (el) |
SI (1) | SI2244696T1 (el) |
WO (1) | WO2009090027A2 (el) |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN172051B (el) * | 1987-12-11 | 1993-03-27 | Hoechst Ag | |
JP2880243B2 (ja) * | 1989-04-18 | 1999-04-05 | 武田薬品工業株式会社 | アスコルビン酸カルシウム造粒物 |
EP0859554B1 (de) * | 1995-10-27 | 2002-05-22 | Givaudan SA | Aromengranulat |
MY117538A (en) | 1997-05-28 | 2004-07-31 | Isegen South Africa Proprietary Ltd | Production of a food acid mixture containing fumaric acid |
DE19733094A1 (de) * | 1997-07-31 | 1999-02-04 | Merck Patent Gmbh | Formulierung auf der Basis von Ascorbinsäure mit verbesserter Farbstabilität |
EP0901786B1 (en) * | 1997-08-11 | 2007-06-13 | Pfizer Products Inc. | Solid pharmaceutical dispersions with enhanced bioavailability |
US5902844A (en) * | 1998-02-02 | 1999-05-11 | Applied Analytical Industries, Inc. | Spray drying of pharmaceutical formulations containing amino acid-based materials |
TWI223598B (en) * | 1998-06-22 | 2004-11-11 | Pfizer Ireland Pharmaceuticals | An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate |
JP4290792B2 (ja) * | 1999-01-11 | 2009-07-08 | カルピス株式会社 | 造粒物、その製法及びこれを用いた錠剤 |
ES2213560T3 (es) * | 1999-06-29 | 2004-09-01 | Aeromatic-Fielder Ag | Procedimiento para la granulacion de un material en forma de particulas. |
US20020193301A1 (en) * | 1999-08-19 | 2002-12-19 | Stem Cell Pharmaceuticals, Inc. | TGF-alpha polypeptides, functional fragments and methods of use therefor |
GB0003782D0 (en) * | 2000-02-17 | 2000-04-05 | Dumex Ltd As | Process |
DE10012199A1 (de) * | 2000-03-13 | 2001-09-20 | Haarmann & Reimer Gmbh | Eingekapselte Substanzen mit kontrollierter Freisetzung |
JP2001294524A (ja) * | 2000-04-12 | 2001-10-23 | Taisho Pharmaceut Co Ltd | アセトアミノフェン配合内服固形製剤 |
AU2002257104B2 (en) * | 2001-04-03 | 2006-02-09 | Merck Sharp & Dohme Corp. | Antifungal composition with enhanced bioavailability |
US6531153B2 (en) * | 2001-05-29 | 2003-03-11 | Drugtech Corporation | Composition with sustained release of levodopa and carbidopa |
ITMI20012572A1 (it) * | 2001-12-06 | 2003-06-06 | Istituto Biochimico Italiano | Microgranuli di acido ursodesossicolico |
DE10209982A1 (de) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma | Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe |
DE10322062A1 (de) * | 2003-05-15 | 2004-12-02 | Glatt Ingenieurtechnik Gmbh | Verfahren und Vorrichtung zum Aufbringen von Flüssigkeiten in eine Feststoffströmung eines Strahlschichtapparates |
DE10325989A1 (de) * | 2003-06-07 | 2005-01-05 | Glatt Gmbh | Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung |
KR100629771B1 (ko) * | 2004-01-27 | 2006-09-28 | 씨제이 주식회사 | 결정성이 감소되거나 무정형화된 올티프라즈의 제조방법 |
US20080095850A1 (en) * | 2004-11-04 | 2008-04-24 | Ho Jennifer S | Process for Granulating Particles |
WO2006102964A2 (en) * | 2005-03-29 | 2006-10-05 | Evonik Röhm Gmbh | Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release |
JP2007297313A (ja) * | 2006-04-28 | 2007-11-15 | Lion Corp | 生薬造粒粒子の製造方法および生薬造粒粒子、錠剤 |
US20070281927A1 (en) * | 2006-06-06 | 2007-12-06 | Shanthakumar Tyavanagimatt | Anti-inflammatory and analgesic compositions and related methods |
AR062320A1 (es) * | 2006-08-14 | 2008-10-29 | Boehringer Ingelheim Int | Formulaciones de flibanserina y metodo para fabricarlas |
EP1958520A3 (de) * | 2007-02-09 | 2013-04-03 | Symrise AG | Wirbelschichtgranulate mit hohem Fruchtanteil |
-
2008
- 2008-01-17 DE DE102008004893A patent/DE102008004893A1/de not_active Ceased
-
2009
- 2009-01-12 EP EP15172814.4A patent/EP2949320A1/de not_active Ceased
- 2009-01-12 US US12/863,336 patent/US20110097411A1/en not_active Abandoned
- 2009-01-12 EP EP09702374.1A patent/EP2244696B1/de active Active
- 2009-01-12 PT PT97023741T patent/PT2244696E/pt unknown
- 2009-01-12 DK DK09702374.1T patent/DK2244696T3/en active
- 2009-01-12 ES ES09702374.1T patent/ES2552172T3/es active Active
- 2009-01-12 HU HUE09702374A patent/HUE026364T2/en unknown
- 2009-01-12 WO PCT/EP2009/000124 patent/WO2009090027A2/de active Application Filing
- 2009-01-12 SI SI200931304T patent/SI2244696T1/sl unknown
- 2009-01-12 PL PL09702374T patent/PL2244696T3/pl unknown
-
2014
- 2014-03-13 US US14/209,056 patent/US11191726B2/en active Active
-
2015
- 2015-04-07 US US14/680,281 patent/US20150209286A1/en not_active Abandoned
- 2015-10-26 HR HRP20151132TT patent/HRP20151132T1/hr unknown
- 2015-11-03 CY CY20151100979T patent/CY1117126T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US20110097411A1 (en) | 2011-04-28 |
WO2009090027A3 (de) | 2010-05-06 |
SI2244696T1 (sl) | 2016-01-29 |
US20140193509A1 (en) | 2014-07-10 |
HUE026364T2 (en) | 2016-06-28 |
DE102008004893A1 (de) | 2009-07-23 |
HRP20151132T1 (hr) | 2015-12-18 |
PL2244696T3 (pl) | 2016-01-29 |
EP2949320A1 (de) | 2015-12-02 |
ES2552172T3 (es) | 2015-11-26 |
WO2009090027A2 (de) | 2009-07-23 |
EP2244696A2 (de) | 2010-11-03 |
WO2009090027A8 (de) | 2009-10-08 |
US20150209286A1 (en) | 2015-07-30 |
PT2244696E (pt) | 2015-11-19 |
EP2244696B1 (de) | 2015-08-05 |
US11191726B2 (en) | 2021-12-07 |
DK2244696T3 (en) | 2015-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123162T1 (el) | Ελεγχομενης αποδεσμευσης φαρμακευτικα σκευασματα νιταζοξανιδης | |
CY1120407T1 (el) | Φαρμακοτεχνικες μορφες ινσουλινων μακρας-δρασεως | |
CY1121877T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει πιμοβενδανη | |
CY1122128T1 (el) | Θεραπεια ενζυμικης αντικαταστασης με κλιμακωση δοσης για αντιμετωπιση ανεπαρκειας σε οξινη σφιγγομυελιναση | |
CY1119518T1 (el) | Τροποποιημενα αντιγονα φυματιωσης | |
CY1118714T1 (el) | Υψηλης συγγενειας ανθρωπινα αντισωματα κατα του ανθρωπινου ενεργοποιουμενου απο πρωτεαση υποδοχεα-2 | |
CY1119582T1 (el) | Υδατικα παρασκευασματα ινσουλινης, που περιεχουν μεθειονινη | |
CY1121742T1 (el) | Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων | |
TR201902233T4 (tr) | Hızlı çözünen katı dozaj formu. | |
BR112012015721A2 (pt) | modificação covalente de proteínas dirigida por ligante | |
UY31673A1 (es) | "derivados heterocíclicos de urea y métodos de uso de los mismos-211" | |
MX2013000636A (es) | Nanoparticulas para encapsulacion de compuestos, su obtencion y uso. | |
CL2008001123A1 (es) | Compuestos derivados de acido lipoico; formulacion farmaceutica que lo comprende; y uso en el tratamiento del cancer. | |
CY1119036T1 (el) | Νεοι αγωνιστες του υποδοχεα τυπου 2 της αγγειοτενσινης (ατ2) και χρησεις τους | |
CY1118968T1 (el) | Αυξημενη βιοδιαθεσιμοτητα δραστικης ουσιας σε θεραπεια ναλτρεξονης | |
CY1116111T1 (el) | Τοπικη συνθεση για τη θεραπεια της ακτινικης κερατωσης | |
CY1118032T1 (el) | Διεργασιες για την εμπορικη παρασκευη φαρμακευτικα δραστικου παραγοντα | |
CY1114190T1 (el) | Νεα μορφη χορηγησης της ρασεκαδοτριλης | |
CY1120240T1 (el) | Απο του στοματος χορηγουμενο παρασκευασμα δισκιου ενωσης τετρακυκλινης | |
CY1110097T1 (el) | Διπλοστοιβαδικο δισκιο για προληψη καρδιαγγειακων συμβαντων | |
CR20150266A (es) | Formulaciones de liberación modificada para oprozomib | |
BR112012013139A2 (pt) | oligopeptídeos imp-3 e vacinas incluindo os mesmos | |
CY1118967T1 (el) | Φαρμακευτικες συνθεσεις υψηλης δοσης βιοτινης | |
CY1113641T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει aleglitazar | |
CY1108711T1 (el) | Συνθεσεις βενζοθειαζολιου και η χρηση αυτων |